What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Myocardial infarction
J. Wouter Jukema mainly investigates Internal medicine, Genome-wide association study, Cardiology, Genetics and Coronary artery disease.
His biological study spans a wide range of topics, including Endocrinology and Surgery.
His Genome-wide association study research is multidisciplinary, relying on both Case-control study, Genetic association, Bioinformatics and Medical genetics.
His studies deal with areas such as Positive predicative value, Multislice, Radiology and Vascular disease as well as Coronary artery disease.
His Radiology research incorporates themes from Circulatory system and Revascularization.
J. Wouter Jukema combines subjects such as Stroke and Hazard ratio with his study of Myocardial infarction.
His most cited work include:
- Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial (2750 citations)
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials (1677 citations)
- Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease (1452 citations)
What are the main themes of his work throughout his whole career to date?
J. Wouter Jukema mainly focuses on Internal medicine, Cardiology, Coronary artery disease, Endocrinology and Genome-wide association study.
J. Wouter Jukema regularly links together related areas like Surgery in his Internal medicine studies.
As part of one scientific family, J. Wouter Jukema deals mainly with the area of Cardiology, narrowing it down to issues related to the Hazard ratio, and often Stroke and Proportional hazards model.
As a member of one scientific family, J. Wouter Jukema mostly works in the field of Coronary artery disease, focusing on Radiology and, on occasion, Coronary angiography and Circulatory system.
His Endocrinology study combines topics from a wide range of disciplines, such as Apolipoprotein E and Risk factor.
His Genome-wide association study research is multidisciplinary, incorporating perspectives in Genetic association, Bioinformatics and Medical genetics.
He most often published in these fields:
- Internal medicine (77.56%)
- Cardiology (46.35%)
- Coronary artery disease (30.17%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (77.56%)
- Cardiology (46.35%)
- Genome-wide association study (18.68%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Internal medicine, Cardiology, Genome-wide association study, Genetics and Acute coronary syndrome.
The study incorporates disciplines such as Alirocumab and Endocrinology in addition to Internal medicine.
Cardiology connects with themes related to Odds ratio in his study.
The Genome-wide association study study combines topics in areas such as PR interval, Disease, Genetic association and Medical genetics.
His Hazard ratio study incorporates themes from Body mass index, Prospective cohort study, Proportional hazards model and Pravastatin.
The concepts of his Myocardial infarction study are interwoven with issues in Coronary artery disease, Residual risk and Stroke.
Between 2017 and 2021, his most popular works were:
- Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps. (503 citations)
- Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits. (284 citations)
- Multi-Ethnic Genome-wide Association Study for Atrial Fibrillation (229 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Myocardial infarction
His primary scientific interests are in Internal medicine, Genome-wide association study, Genetics, Cardiology and Alirocumab.
His study in Acute coronary syndrome, Myocardial infarction, Randomized controlled trial, Lipoprotein and Lipoprotein is done as part of Internal medicine.
His study in Myocardial infarction is interdisciplinary in nature, drawing from both Stroke and LDL Cholesterol Lipoproteins.
J. Wouter Jukema interconnects Bioinformatics, Medical genetics, Disease, Genetic association and Minor allele frequency in the investigation of issues within Genome-wide association study.
His research integrates issues of Cognition and Cardiac conduction in his study of Genetics.
His work deals with themes such as Dialysis, Interquartile range and Hazard ratio, which intersect with Cardiology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
